VEA
ALBO

Virtus ETF Advisers’s Albireo Pharma Inc ALBO Stock Holding History

Virtus ETF Advisers’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,197
Closed -$193K – 412
2021
Q3 		$193K Sell
6,197
-326
-5% -$10.1K 0.08% 281
2021
Q2 		$229K Sell
6,523
-803
-11% -$26.1K 0.09% 245
2021
Q1 		$258K Buy
7,326
+134
+2% +$4.95K 0.11% 281
2020
Q4 		$270K Buy
+7,192
New +$262K 0.11% 277
2018
Q4 		– Sell
-14,240
Closed -$469K – 404
2018
Q3 		$469K Sell
14,240
-10,448
-42% -$342K 0.05% 133
2018
Q2 		$876K Buy
+24,688
New +$800K 0.77% 14

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Virtus ETF Advisers's ALBO Position: Q4 2021 in Review

Virtus ETF Advisers sold out of Albireo Pharma Inc (ALBO) in Q4 2021, closing a stake of 6,197 shares — an estimated $193K sold.

Virtus ETF Advisers first reported a position in ALBO in Q2 2018 and held it in 6 quarters. The position peaked at $876K in Q2 2018. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2021.

  • Virtus ETF Advisers reported no remaining Albireo Pharma Inc position as of Q4 2021 after selling out during the quarter.
  • Virtus ETF Advisers sold 6,197 Albireo Pharma Inc shares in Q4 2021, an estimated $193K.
  • Virtus ETF Advisers first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 6 quarters.
  • Virtus ETF Advisers's Albireo Pharma Inc position peaked at $876K in Q2 2018.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2021.

Based on Virtus ETF Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.